IOL Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 ,inter alia, to consider and approve the Un-audited ....
IOLCP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
IOL Chemicals & Pharmaceuticals has informed the stock exchanges that its Board of Directors will meet on Wednesday, 11 February 2026. The Board will consider and approve the un-audited financial results for the quarter and nine months ended 31 December 2025 (Q3 FY26). It will also consider declaring an Interim Dividend for FY 2025-26. The trading window for designated persons remains closed and will reopen on 14 February 2026, i.e. 48 hours after the results are made public. The notice is filed under SEBI LODR Regulation 29.
This is a routine advance intimation of an upcoming results announcement, not the results themselves. Shareholders should watch 11 February for Q3 numbers and any dividend declaration, which could be a short-term positive trigger for the stock if announced.